|
Cost-minimization analysis of using tumor cell-free DNA as monitoring tool in cancer immunotherapy. |
|
|
Research Funding - Amedes |
|
|
Employment - Former: Western Regional Medical Center |
Stock and Other Ownership Interests - Circulogene Theranostics |
Consulting or Advisory Role - Angiex; Circulogene Theranostics; Gerson Lehrman Group; Guidepoint Global; Idea Pharma; Paradigm; Viomics |
Speakers' Bureau - Ignyta; Pfizer |
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; Tesaro |
Other Relationship - Arizona Medical Board |
|
|
Employment - Chronix Biomedical |
Stock and Other Ownership Interests - Chronix Biomedical |
Patents, Royalties, Other Intellectual Property - Inventor of several patents filed by Chronix Biomedical |
Travel, Accommodations, Expenses - Chronix Biomedical |
|
|
No Relationships to Disclose |
|
|
|
|
|
Employment - Chronix Biomedical |
Leadership - Chronix Biomedical |
Stock and Other Ownership Interests - Chronix Biomedical |
Research Funding - Chronix Biomedical |
Patents, Royalties, Other Intellectual Property - Several patents in field of medical diagnostics (Inst) |
Travel, Accommodations, Expenses - Chronix Biomedical |
|
J.-Matthias Graf von der Schulenburg |
No Relationships to Disclose |